Effect of probiotic supplement in tuberculosis patients
Phase 4
- Conditions
- Health Condition 1: A150- Tuberculosis of lung
- Registration Number
- CTRI/2023/11/059867
- Lead Sponsor
- Sri Siddhartha Medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly diagnosed Pulmonary TB patients, aged 18-65 years ( as per WHO diagnostic criteria)
Written consent from the patient
Exclusion Criteria
Patients of Extrapulmonary TB
Pregnant women
Immunocompromised patients and patients on immunosuppresive agents
Patients with comorbidities like cardiovascular diseases (Hypertension, Ischaemic heart diseases, Cardiomyopathies), Diabetes, gastrointestinal disease, liver malfunction, tumor, severe mental or psychological illness, or cognitive impairment
The use of probiotic supplementation within the previous 2 months.
No informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method